Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology

The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges for early diagnosis and yet allows for the possibility of the development of disease modifying treatments for secondary prevention. It is, therefore, of importance to develop biomarkers, in particular, in the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Baird, Alison L., Westwood, Sarah, Lovestone, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644785/
https://www.ncbi.nlm.nih.gov/pubmed/26635716
http://dx.doi.org/10.3389/fneur.2015.00236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644785/
https://www.ncbi.nlm.nih.gov/pubmed/26635716
http://dx.doi.org/10.3389/fneur.2015.00236

Ejemplares similares